Direkt zum Inhalt

Owner only: item control page
Lamers, Leida M. ; Stupp, Roger ; van den Bent, Martin J. ; Al, Maiwenn J. ; Gorlia, Thierry ; Wasserfallen, Jean-Blaise ; Mittmann, Nicole ; Jin Seung, Soo ; Crott, Ralph ; Uyl-de Groot, Carin A.

Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme: a report from the EORTC 26981/22981 NCI-C CE3 Intergroup Study

Lamers, Leida M., Stupp, Roger, van den Bent, Martin J., Al, Maiwenn J., Gorlia, Thierry, Wasserfallen, Jean-Blaise, Mittmann, Nicole, Jin Seung, Soo, Crott, Ralph and Uyl-de Groot, Carin A. (2008) Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme: a report from the EORTC 26981/22981 NCI-C CE3 Intergroup Study. Cancer 112 (6), pp. 1337-1344.

Date of publication of this fulltext: 17 Jan 2014 09:24
Article



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleCancer
Publisher:Wiley
Volume:112
Number of Issue or Book Chapter:6
Page Range:pp. 1337-1344
Date2008
Additional InformationEORTC 26981/22981 NCI-C CE3 Intergroup Study
InstitutionsMedicine > Zentren des Universitätsklinikums Regensburg > Zentrum für Hirntumore (ZHT)
Identification Number
ValueType
18213621PubMed ID
10.1002/cncr.23297DOI
Classification
NotationType
AdolescentMESH
AdultMESH
AgedMESH
Antineoplastic Agents, Alkylating/therapeutic useMESH
Brain Neoplasms/radiotherapyMESH
Cost-Benefit AnalysisMESH
Dacarbazine/therapeutic useMESH
Disease-Free SurvivalMESH
Follow-Up StudiesMESH
Glioblastoma/radiotherapyMESH
Health Care CostsMESH
HumansMESH
Middle AgedMESH
Quality-Adjusted Life YearsMESH
Survival RateMESH
Subjects600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgUnknown
Item ID29325

Export bibliographical data

Owner only: item control page

nach oben